Industry Research Reports

Home > Reports > Medical Care > Intravenous(IV) Therapy and Vein Access - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Intravenous(IV) Therapy and Vein Access - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Medical Care

Published: 2024-01-24

Pages: 84 Pages

Report ld: 2339392

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

IV therapy and vein access devices market is categorized into implantable ports, intravenous catheters, hypodermic needles, infusion pumps, and other products.

The global market for Intravenous(IV) Therapy and Vein Access was estimated to be worth US$ 35670 million in 2023 and is forecast to a readjusted size of US$ 46480 million by 2030 with a CAGR of 3.4% during the forecast period 2024-2030

Intravenous(IV) Therapy and Vein Access Market Size

M= millions and B=billions

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Intravenous(IV) Therapy and Vein Access, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Intravenous(IV) Therapy and Vein Access by region & country, by Type, and by Application.

The Intravenous(IV) Therapy and Vein Access market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intravenous(IV) Therapy and Vein Access.

Market Segmentation

Report Metric
Details
Report Title
Intravenous(IV) Therapy and Vein Access - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Forecasted Market Size in 2030
US$ 46480 million
CAGR(2024-2030)
3.4%
Market Size Available for Years
2019-2030
Global Intravenous(IV) Therapy and Vein Access Companies Covered
B. Braun, Baxter International, Becton Dickinson, C. R. Bard, Fresenius Kabi, Hospira(ICU Medical), Medtronic, Smiths Group, Teleflex
Global Intravenous(IV) Therapy and Vein Access Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Intravenous(IV) Therapy and Vein Access Market, Segment by Type
Infusion Pumps

Implantable Ports

Intravenous Catheters

Hypodermic Needles

Other
Global Intravenous(IV) Therapy and Vein Access Market, Segment by Application
Hospital

Clinics

Other
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Intravenous(IV) Therapy and Vein Access manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Intravenous(IV) Therapy and Vein Access in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Intravenous(IV) Therapy and Vein Access in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

 1 Market Overview
    1.1 Intravenous(IV) Therapy and Vein Access Product Introduction
    1.2 Global Intravenous(IV) Therapy and Vein Access Market Size Forecast
    1.3 Intravenous(IV) Therapy and Vein Access Market Trends & Drivers
        1.3.1 Intravenous(IV) Therapy and Vein Access Industry Trends
        1.3.2 Intravenous(IV) Therapy and Vein Access Market Drivers & Opportunity
        1.3.3 Intravenous(IV) Therapy and Vein Access Market Challenges
        1.3.4 Intravenous(IV) Therapy and Vein Access Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Intravenous(IV) Therapy and Vein Access Players Revenue Ranking (2023)
    2.2 Global Intravenous(IV) Therapy and Vein Access Revenue by Company (2019-2024)
    2.3 Key Companies Intravenous(IV) Therapy and Vein Access Manufacturing Base Distribution and Headquarters
    2.4 Key Companies Intravenous(IV) Therapy and Vein Access Product Offered
    2.5 Key Companies Time to Begin Mass Production of Intravenous(IV) Therapy and Vein Access
    2.6 Intravenous(IV) Therapy and Vein Access Market Competitive Analysis
        2.6.1 Intravenous(IV) Therapy and Vein Access Market Concentration Rate (2019-2024)
        2.6.2 Global 5 and 10 Largest Companies by Intravenous(IV) Therapy and Vein Access Revenue in 2023
        2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intravenous(IV) Therapy and Vein Access as of 2023)
    2.7 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Infusion Pumps
        3.1.2 Implantable Ports
        3.1.3 Intravenous Catheters
        3.1.4 Hypodermic Needles
        3.1.5 Other
    3.2 Global Intravenous(IV) Therapy and Vein Access Sales Value by Type
        3.2.1 Global Intravenous(IV) Therapy and Vein Access Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Intravenous(IV) Therapy and Vein Access Sales Value, by Type (2019-2030)
        3.2.3 Global Intravenous(IV) Therapy and Vein Access Sales Value, by Type (%) (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Hospital
        4.1.2 Clinics
        4.1.3 Other
    4.2 Global Intravenous(IV) Therapy and Vein Access Sales Value by Application
        4.2.1 Global Intravenous(IV) Therapy and Vein Access Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Intravenous(IV) Therapy and Vein Access Sales Value, by Application (2019-2030)
        4.2.3 Global Intravenous(IV) Therapy and Vein Access Sales Value, by Application (%) (2019-2030)

 5 Segmentation by Region
    5.1 Global Intravenous(IV) Therapy and Vein Access Sales Value by Region
        5.1.1 Global Intravenous(IV) Therapy and Vein Access Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Intravenous(IV) Therapy and Vein Access Sales Value by Region (2019-2024)
        5.1.3 Global Intravenous(IV) Therapy and Vein Access Sales Value by Region (2025-2030)
        5.1.4 Global Intravenous(IV) Therapy and Vein Access Sales Value by Region (%), (2019-2030)
    5.2 North America
        5.2.1 North America Intravenous(IV) Therapy and Vein Access Sales Value, 2019-2030
        5.2.2 North America Intravenous(IV) Therapy and Vein Access Sales Value by Country (%), 2023 VS 2030
    5.3 Europe
        5.3.1 Europe Intravenous(IV) Therapy and Vein Access Sales Value, 2019-2030
        5.3.2 Europe Intravenous(IV) Therapy and Vein Access Sales Value by Country (%), 2023 VS 2030
    5.4 Asia Pacific
        5.4.1 Asia Pacific Intravenous(IV) Therapy and Vein Access Sales Value, 2019-2030
        5.4.2 Asia Pacific Intravenous(IV) Therapy and Vein Access Sales Value by Country (%), 2023 VS 2030
    5.5 South America
        5.5.1 South America Intravenous(IV) Therapy and Vein Access Sales Value, 2019-2030
        5.5.2 South America Intravenous(IV) Therapy and Vein Access Sales Value by Country (%), 2023 VS 2030
    5.6 Middle East & Africa
        5.6.1 Middle East & Africa Intravenous(IV) Therapy and Vein Access Sales Value, 2019-2030
        5.6.2 Middle East & Africa Intravenous(IV) Therapy and Vein Access Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Intravenous(IV) Therapy and Vein Access Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Intravenous(IV) Therapy and Vein Access Sales Value
    6.3 United States
        6.3.1 United States Intravenous(IV) Therapy and Vein Access Sales Value, 2019-2030
        6.3.2 United States Intravenous(IV) Therapy and Vein Access Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Intravenous(IV) Therapy and Vein Access Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Intravenous(IV) Therapy and Vein Access Sales Value, 2019-2030
        6.4.2 Europe Intravenous(IV) Therapy and Vein Access Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Intravenous(IV) Therapy and Vein Access Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Intravenous(IV) Therapy and Vein Access Sales Value, 2019-2030
        6.5.2 China Intravenous(IV) Therapy and Vein Access Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Intravenous(IV) Therapy and Vein Access Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Intravenous(IV) Therapy and Vein Access Sales Value, 2019-2030
        6.6.2 Japan Intravenous(IV) Therapy and Vein Access Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Intravenous(IV) Therapy and Vein Access Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Intravenous(IV) Therapy and Vein Access Sales Value, 2019-2030
        6.7.2 South Korea Intravenous(IV) Therapy and Vein Access Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Intravenous(IV) Therapy and Vein Access Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Intravenous(IV) Therapy and Vein Access Sales Value, 2019-2030
        6.8.2 Southeast Asia Intravenous(IV) Therapy and Vein Access Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Intravenous(IV) Therapy and Vein Access Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Intravenous(IV) Therapy and Vein Access Sales Value, 2019-2030
        6.9.2 India Intravenous(IV) Therapy and Vein Access Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Intravenous(IV) Therapy and Vein Access Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 B. Braun
        7.1.1 B. Braun Profile
        7.1.2 B. Braun Main Business
        7.1.3 B. Braun Intravenous(IV) Therapy and Vein Access Products, Services and Solutions
        7.1.4 B. Braun Intravenous(IV) Therapy and Vein Access Revenue (US$ Million) & (2019-2024)
        7.1.5 B. Braun Recent Developments
    7.2 Baxter International
        7.2.1 Baxter International Profile
        7.2.2 Baxter International Main Business
        7.2.3 Baxter International Intravenous(IV) Therapy and Vein Access Products, Services and Solutions
        7.2.4 Baxter International Intravenous(IV) Therapy and Vein Access Revenue (US$ Million) & (2019-2024)
        7.2.5 Baxter International Recent Developments
    7.3 Becton Dickinson
        7.3.1 Becton Dickinson Profile
        7.3.2 Becton Dickinson Main Business
        7.3.3 Becton Dickinson Intravenous(IV) Therapy and Vein Access Products, Services and Solutions
        7.3.4 Becton Dickinson Intravenous(IV) Therapy and Vein Access Revenue (US$ Million) & (2019-2024)
        7.3.5 C. R. Bard Recent Developments
    7.4 C. R. Bard
        7.4.1 C. R. Bard Profile
        7.4.2 C. R. Bard Main Business
        7.4.3 C. R. Bard Intravenous(IV) Therapy and Vein Access Products, Services and Solutions
        7.4.4 C. R. Bard Intravenous(IV) Therapy and Vein Access Revenue (US$ Million) & (2019-2024)
        7.4.5 C. R. Bard Recent Developments
    7.5 Fresenius Kabi
        7.5.1 Fresenius Kabi Profile
        7.5.2 Fresenius Kabi Main Business
        7.5.3 Fresenius Kabi Intravenous(IV) Therapy and Vein Access Products, Services and Solutions
        7.5.4 Fresenius Kabi Intravenous(IV) Therapy and Vein Access Revenue (US$ Million) & (2019-2024)
        7.5.5 Fresenius Kabi Recent Developments
    7.6 Hospira(ICU Medical)
        7.6.1 Hospira(ICU Medical) Profile
        7.6.2 Hospira(ICU Medical) Main Business
        7.6.3 Hospira(ICU Medical) Intravenous(IV) Therapy and Vein Access Products, Services and Solutions
        7.6.4 Hospira(ICU Medical) Intravenous(IV) Therapy and Vein Access Revenue (US$ Million) & (2019-2024)
        7.6.5 Hospira(ICU Medical) Recent Developments
    7.7 Medtronic
        7.7.1 Medtronic Profile
        7.7.2 Medtronic Main Business
        7.7.3 Medtronic Intravenous(IV) Therapy and Vein Access Products, Services and Solutions
        7.7.4 Medtronic Intravenous(IV) Therapy and Vein Access Revenue (US$ Million) & (2019-2024)
        7.7.5 Medtronic Recent Developments
    7.8 Smiths Group
        7.8.1 Smiths Group Profile
        7.8.2 Smiths Group Main Business
        7.8.3 Smiths Group Intravenous(IV) Therapy and Vein Access Products, Services and Solutions
        7.8.4 Smiths Group Intravenous(IV) Therapy and Vein Access Revenue (US$ Million) & (2019-2024)
        7.8.5 Smiths Group Recent Developments
    7.9 Teleflex
        7.9.1 Teleflex Profile
        7.9.2 Teleflex Main Business
        7.9.3 Teleflex Intravenous(IV) Therapy and Vein Access Products, Services and Solutions
        7.9.4 Teleflex Intravenous(IV) Therapy and Vein Access Revenue (US$ Million) & (2019-2024)
        7.9.5 Teleflex Recent Developments

 8 Industry Chain Analysis
    8.1 Intravenous(IV) Therapy and Vein Access Industrial Chain
    8.2 Intravenous(IV) Therapy and Vein Access Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Intravenous(IV) Therapy and Vein Access Sales Model
        8.5.2 Sales Channel
        8.5.3 Intravenous(IV) Therapy and Vein Access Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

List of Tables
    Table 1. Intravenous(IV) Therapy and Vein Access Market Trends
    Table 2. Intravenous(IV) Therapy and Vein Access Market Drivers & Opportunity
    Table 3. Intravenous(IV) Therapy and Vein Access Market Challenges
    Table 4. Intravenous(IV) Therapy and Vein Access Market Restraints
    Table 5. Global Intravenous(IV) Therapy and Vein Access Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Intravenous(IV) Therapy and Vein Access Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Intravenous(IV) Therapy and Vein Access Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Intravenous(IV) Therapy and Vein Access Product Type
    Table 9. Key Companies Time to Begin Mass Production of Intravenous(IV) Therapy and Vein Access
    Table 10. Global Intravenous(IV) Therapy and Vein Access Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intravenous(IV) Therapy and Vein Access as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Intravenous(IV) Therapy and Vein Access Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Intravenous(IV) Therapy and Vein Access Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Intravenous(IV) Therapy and Vein Access Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Intravenous(IV) Therapy and Vein Access Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Intravenous(IV) Therapy and Vein Access Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Intravenous(IV) Therapy and Vein Access Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Intravenous(IV) Therapy and Vein Access Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Intravenous(IV) Therapy and Vein Access Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Intravenous(IV) Therapy and Vein Access Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Intravenous(IV) Therapy and Vein Access Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Intravenous(IV) Therapy and Vein Access Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Intravenous(IV) Therapy and Vein Access Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Intravenous(IV) Therapy and Vein Access Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Intravenous(IV) Therapy and Vein Access Sales Value by Region (2019-2024) & (%)
    Table 27. Global Intravenous(IV) Therapy and Vein Access Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Intravenous(IV) Therapy and Vein Access Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Intravenous(IV) Therapy and Vein Access Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Intravenous(IV) Therapy and Vein Access Sales Value, (2025-2030) & (US$ Million)
    Table 31. B. Braun Basic Information List
    Table 32. B. Braun Description and Business Overview
    Table 33. B. Braun Intravenous(IV) Therapy and Vein Access Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Intravenous(IV) Therapy and Vein Access Business of B. Braun (2019-2024)
    Table 35. B. Braun Recent Developments
    Table 36. Baxter International Basic Information List
    Table 37. Baxter International Description and Business Overview
    Table 38. Baxter International Intravenous(IV) Therapy and Vein Access Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Intravenous(IV) Therapy and Vein Access Business of Baxter International (2019-2024)
    Table 40. Baxter International Recent Developments
    Table 41. Becton Dickinson Basic Information List
    Table 42. Becton Dickinson Description and Business Overview
    Table 43. Becton Dickinson Intravenous(IV) Therapy and Vein Access Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Intravenous(IV) Therapy and Vein Access Business of Becton Dickinson (2019-2024)
    Table 45. Becton Dickinson Recent Developments
    Table 46. C. R. Bard Basic Information List
    Table 47. C. R. Bard Description and Business Overview
    Table 48. C. R. Bard Intravenous(IV) Therapy and Vein Access Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Intravenous(IV) Therapy and Vein Access Business of C. R. Bard (2019-2024)
    Table 50. C. R. Bard Recent Developments
    Table 51. Fresenius Kabi Basic Information List
    Table 52. Fresenius Kabi Description and Business Overview
    Table 53. Fresenius Kabi Intravenous(IV) Therapy and Vein Access Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Intravenous(IV) Therapy and Vein Access Business of Fresenius Kabi (2019-2024)
    Table 55. Fresenius Kabi Recent Developments
    Table 56. Hospira(ICU Medical) Basic Information List
    Table 57. Hospira(ICU Medical) Description and Business Overview
    Table 58. Hospira(ICU Medical) Intravenous(IV) Therapy and Vein Access Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Intravenous(IV) Therapy and Vein Access Business of Hospira(ICU Medical) (2019-2024)
    Table 60. Hospira(ICU Medical) Recent Developments
    Table 61. Medtronic Basic Information List
    Table 62. Medtronic Description and Business Overview
    Table 63. Medtronic Intravenous(IV) Therapy and Vein Access Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Intravenous(IV) Therapy and Vein Access Business of Medtronic (2019-2024)
    Table 65. Medtronic Recent Developments
    Table 66. Smiths Group Basic Information List
    Table 67. Smiths Group Description and Business Overview
    Table 68. Smiths Group Intravenous(IV) Therapy and Vein Access Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Intravenous(IV) Therapy and Vein Access Business of Smiths Group (2019-2024)
    Table 70. Smiths Group Recent Developments
    Table 71. Teleflex Basic Information List
    Table 72. Teleflex Description and Business Overview
    Table 73. Teleflex Intravenous(IV) Therapy and Vein Access Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Intravenous(IV) Therapy and Vein Access Business of Teleflex (2019-2024)
    Table 75. Teleflex Recent Developments
    Table 76. Key Raw Materials Lists
    Table 77. Raw Materials Key Suppliers Lists
    Table 78. Intravenous(IV) Therapy and Vein Access Downstream Customers
    Table 79. Intravenous(IV) Therapy and Vein Access Distributors List
    Table 80. Research Programs/Design for This Report
    Table 81. Key Data Information from Secondary Sources
    Table 82. Key Data Information from Primary Sources
    Table 83. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Intravenous(IV) Therapy and Vein Access Product Picture
    Figure 2. Global Intravenous(IV) Therapy and Vein Access Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Intravenous(IV) Therapy and Vein Access Sales Value (2019-2030) & (US$ Million)
    Figure 4. Intravenous(IV) Therapy and Vein Access Report Years Considered
    Figure 5. Global Intravenous(IV) Therapy and Vein Access Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Intravenous(IV) Therapy and Vein Access Revenue in 2023
    Figure 7. Intravenous(IV) Therapy and Vein Access Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Infusion Pumps Picture
    Figure 9. Implantable Ports Picture
    Figure 10. Intravenous Catheters Picture
    Figure 11. Hypodermic Needles Picture
    Figure 12. Other Picture
    Figure 13. Global Intravenous(IV) Therapy and Vein Access Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 14. Global Intravenous(IV) Therapy and Vein Access Sales Value Market Share by Type, 2023 & 2030
    Figure 15. Product Picture of Hospital
    Figure 16. Product Picture of Clinics
    Figure 17. Product Picture of Other
    Figure 18. Global Intravenous(IV) Therapy and Vein Access Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 19. Global Intravenous(IV) Therapy and Vein Access Sales Value Market Share by Application, 2023 & 2030
    Figure 20. North America Intravenous(IV) Therapy and Vein Access Sales Value (2019-2030) & (US$ Million)
    Figure 21. North America Intravenous(IV) Therapy and Vein Access Sales Value by Country (%), 2023 VS 2030
    Figure 22. Europe Intravenous(IV) Therapy and Vein Access Sales Value (2019-2030) & (US$ Million)
    Figure 23. Europe Intravenous(IV) Therapy and Vein Access Sales Value by Country (%), 2023 VS 2030
    Figure 24. Asia Pacific Intravenous(IV) Therapy and Vein Access Sales Value (2019-2030) & (US$ Million)
    Figure 25. Asia Pacific Intravenous(IV) Therapy and Vein Access Sales Value by Country (%), 2023 VS 2030
    Figure 26. South America Intravenous(IV) Therapy and Vein Access Sales Value (2019-2030) & (US$ Million)
    Figure 27. South America Intravenous(IV) Therapy and Vein Access Sales Value by Country (%), 2023 VS 2030
    Figure 28. Middle East & Africa Intravenous(IV) Therapy and Vein Access Sales Value (2019-2030) & (US$ Million)
    Figure 29. Middle East & Africa Intravenous(IV) Therapy and Vein Access Sales Value by Country (%), 2023 VS 2030
    Figure 30. Key Countries/Regions Intravenous(IV) Therapy and Vein Access Sales Value (%), (2019-2030)
    Figure 31. United States Intravenous(IV) Therapy and Vein Access Sales Value, (2019-2030) & (US$ Million)
    Figure 32. United States Intravenous(IV) Therapy and Vein Access Sales Value by Type (%), 2023 VS 2030
    Figure 33. United States Intravenous(IV) Therapy and Vein Access Sales Value by Application (%), 2023 VS 2030
    Figure 34. Europe Intravenous(IV) Therapy and Vein Access Sales Value, (2019-2030) & (US$ Million)
    Figure 35. Europe Intravenous(IV) Therapy and Vein Access Sales Value by Type (%), 2023 VS 2030
    Figure 36. Europe Intravenous(IV) Therapy and Vein Access Sales Value by Application (%), 2023 VS 2030
    Figure 37. China Intravenous(IV) Therapy and Vein Access Sales Value, (2019-2030) & (US$ Million)
    Figure 38. China Intravenous(IV) Therapy and Vein Access Sales Value by Type (%), 2023 VS 2030
    Figure 39. China Intravenous(IV) Therapy and Vein Access Sales Value by Application (%), 2023 VS 2030
    Figure 40. Japan Intravenous(IV) Therapy and Vein Access Sales Value, (2019-2030) & (US$ Million)
    Figure 41. Japan Intravenous(IV) Therapy and Vein Access Sales Value by Type (%), 2023 VS 2030
    Figure 42. Japan Intravenous(IV) Therapy and Vein Access Sales Value by Application (%), 2023 VS 2030
    Figure 43. South Korea Intravenous(IV) Therapy and Vein Access Sales Value, (2019-2030) & (US$ Million)
    Figure 44. South Korea Intravenous(IV) Therapy and Vein Access Sales Value by Type (%), 2023 VS 2030
    Figure 45. South Korea Intravenous(IV) Therapy and Vein Access Sales Value by Application (%), 2023 VS 2030
    Figure 46. Southeast Asia Intravenous(IV) Therapy and Vein Access Sales Value, (2019-2030) & (US$ Million)
    Figure 47. Southeast Asia Intravenous(IV) Therapy and Vein Access Sales Value by Type (%), 2023 VS 2030
    Figure 48. Southeast Asia Intravenous(IV) Therapy and Vein Access Sales Value by Application (%), 2023 VS 2030
    Figure 49. India Intravenous(IV) Therapy and Vein Access Sales Value, (2019-2030) & (US$ Million)
    Figure 50. India Intravenous(IV) Therapy and Vein Access Sales Value by Type (%), 2023 VS 2030
    Figure 51. India Intravenous(IV) Therapy and Vein Access Sales Value by Application (%), 2023 VS 2030
    Figure 52. Intravenous(IV) Therapy and Vein Access Industrial Chain
    Figure 53. Intravenous(IV) Therapy and Vein Access Manufacturing Cost Structure
    Figure 54. Channels of Distribution (Direct Sales, and Distribution)
    Figure 55. Bottom-up and Top-down Approaches for This Report
    Figure 56. Data Triangulation

IV therapy and vein access devices market is categorized into implantable ports, intravenous catheters, hypodermic needles, infusion pumps, and other products.

The global market for Intravenous(IV) Therapy and Vein Access was estimated to be worth US$ 35670 million in 2023 and is forecast to a readjusted size of US$ 46480 million by 2030 with a CAGR of 3.4% during the forecast period 2024-2030

Market Segmentation

Industry: Medical Care

Published: 2024-01-24

Pages: 84 Pages

Report ld: 2339392

Request Sample

Pre-Order Enquiry

CHOOSE LICENSE TYPE

Single User License

USD 3950.00

Multi Users License

USD 5925.00